Skip to main content
TELCON RF PHARMACEUTICAL. Inc. logo

TELCON RF PHARMACEUTICAL. Inc. — Investor Relations & Filings

Ticker · 200230 ISIN · KR7200230001 KO Manufacturing
Open in API
Filings indexed 351 across all filing types
Latest filing 2026-05-21 Declaration of Voting R…
Country KR South Korea
Listing KO 200230

About TELCON RF PHARMACEUTICAL. Inc.

http://www.telcon-rf.com

TELCON RF PHARMACEUTICAL. Inc. operates across two primary business segments: radio frequency (RF) components and pharmaceuticals. The RF division specializes in the development, manufacturing, and global sale of components for wireless communication equipment. Its main products include RF coaxial connectors, cable assemblies, coaxial couplers, and distributors. The pharmaceutical and biotechnology division is engaged in the development and sale of medicinal products.

Recent filings

Filing Released Lang Actions
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled “임시주주총회결과” and details the date of the extraordinary shareholders’ meeting, record date, agenda item (capital reduction), and the voting results (approval rates). This matches a Declaration of Voting Results for an EGM. Therefore, it is classified as DVA.
2026-05-21 Welsh
타인에대한채무보증결정
Capital/Financing Update Classification · 80% confidence The document is a formal announcement of the board’s decision to provide a guarantee for another party’s debt, detailing borrower, creditor, amounts, equity ratios, guarantee period, and board resolution date. This is a financing-related corporate action (off-balance‐sheet guarantee) rather than a full financial report, management change, dividend notice, legal briefing, or M&A. It falls under updates on the company’s financing activities and capital commitments. Therefore, the appropriate category is Capital/Financing Update (CAP).
2026-05-15 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is titled “분기보고서” (Quarterly Report) for the period January 1, 2026 to March 31, 2026 and contains full financial statements (연결재무제표, 재무제표 주석), management’s discussion and other sections standard in an interim/quarterly filing. It is the actual report itself, not just an announcement. This matches our definition for Interim / Quarterly Report (IR). Q1 2026
2026-05-15 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 85% confidence The document is a formal notice (‘소집공고’) convening the 28th Extraordinary Shareholders’ Meeting, including date/time, location, meeting agenda, proxy arrangements, electronic voting instructions, and background business information. It is sent to shareholders to provide information and solicit their votes. This fits the definition of a Proxy Solicitation & Information Statement (PSI).
2026-04-29 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 98% confidence The document is titled “의결권대리행사권유참고서류” and provides detailed proxy solicitation information for an upcoming shareholders’ meeting, including instructions on electronic and paper proxy voting, timeline, involved parties, agenda (capital reduction), and related schedules. This matches the definition of a Proxy Solicitation & Information Statement, not a simple announcement or an annual/interim report.
2026-04-29 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 92% confidence The document is an ‘임원ㆍ주요주주 특정증권등 소유상황보고서’ (insider ownership report), detailing share counts and changes by an executive/major shareholder. This matches the definition of Director’s Dealing (insider share transactions).
2026-04-17 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.